Non-ANCA Leucocytoclasic Vasculitis Induced by Sofosbuvir / Ledipasvir Treatment: A case report.
Sign Up to like & getrecommendations! Published in 2023 at "Current drug safety"
DOI: 10.2174/1574886318666230406083939
Abstract: BACKGROUND The development of direct-acting antivirals directed against the Hepatitis C Virus has dramatically modified the therapeutic approach to chronic hepatic viral disease. Larger use of such drugs has also led to increasing reports about… read more here.
Keywords: vasculitis; sofosbuvir ledipasvir; leucocytoclasic vasculitis; non anca ... See more keywords